Mounjaro constipation help Mounjaro (tirzepatide) is a dual agonist of GIP and GLP-1 receptors, highly effective for blood sugar control and weight loss
In fact, around 50% of adults taking GLP-1 medications struggle to afford them , emphasizing the urgent need for more accessible options
Timing of administration : Taking tirzepatide at a consistent time each week, preferably when patients can rest if needed, may improve tolerability
They are susceptible to degradation pathways that small molecules simply do not face, including deamidation, oxidation, aggregation, and hydrolysis
Clinical trials and patient outcomes support this claim, and the FDA has approved semaglutide for this purpose
But high-profile journals were publishing papers that downplayed or omitted my contributions